Skip to main content
Caplight Logo









Malcisbo AG

Malcisbo AG

Private
SchlierenHealthcare & Life Scienceshttp://malcisbo.com/

Last Round

Seed

Sep 19, 2011

Total Funding Raised

$4.33M

Company Overview

Malcisbo AG is a biotechnology company that develops carbohydrate-based veterinary vaccines using a novel glycoengineering platform to prevent bacterial infections in farm animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

glycoengineeringglycoconjugate vaccinesveterinary vaccinebiotech licensinganimal healthvaccine platformbacterial vaccinezoonotic diseaseantibiotic alternativesvaccine R&Dlivestock healthbiotech spin-offpharma partneringagtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Malcisbo AG Comparables

Compare Malcisbo AG with similar companies based on industry and business-model similarity.

Malcisbo AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VaxAlta Inc.
90%
ArkVax
88%
Santella AG
80%

Malcisbo AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 19, 2011
AcceleratorNov 9, 2010
GrantJun 8, 2010

Key People

Founding team and executive leadership

Lino Camponovo

CEO

Executive Team

Malcisbo AG Investors

Notable investors and investment history

Malcisbo AG investors
InvestorRounds
RedalpineSeed
Venture KickGrant, Accelerator
Zurcher KantonalbankSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2010

    $130K raised from Venture Kick

Malcisbo AG Filings

Explore SEC and related filing metadata, where available.

Malcisbo AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Malcisbo AG's valuation, stock price, and market status.

Is Malcisbo a public or private company?

Malcisbo is a private company.

What is the current stock price of Malcisbo?

Malcisbo is a private company with no public stock price. No recent secondary market data is available.

How much is Malcisbo worth (valuation)?

Valuation information for Malcisbo is not publicly available.

Can I buy Malcisbo stock?

Malcisbo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Malcisbo's last funding round?

Malcisbo's most recent funding round was Seed on September 19, 2011.

Who are the main investors in Malcisbo?

Key investors in Malcisbo include Venture Kick, Zurcher Kantonalbank.

Will Malcisbo IPO soon?

No public IPO plans have been announced for Malcisbo.

How can I track Malcisbo secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Malcisbo's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range1
Year Founded2010
Last FundingSep 19, 2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?